Get started
Author

Christian Mottet

Observed names: C MOTTET, C Mottet, C. Mottet, Christian Mottet C, Mottet, C., Mottet, Christian
Observed institutions: University of Bern, University of Basel, University of Zurich, Triemli Hospital, Universitair Ziekenhuis Leuven, University Hospital of Bern, Centre Hospitalier Universitaire Vaudois, University Hospital of Basel, University of Oxford, Ospedale regionale di Lugano, University Hospital Zurich, Hôpital Saint-Antoine, Hospital Neuchâtel, Institute of Social and Preventive Medicine, Centro Hospitalar de Vila Nova de Gaia, Hôpital de Sion, Centre universitaire de médecine générale et santé publique, Lausanne, European Crohn's and Colitis Organisation, Hôpital du Valais, Université Pierre-et-Marie-Curie, Réseau hospitalier neuchâtelois, University of Lausanne, KU Leuven
OpenAlex ID: A5107871156
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
2003 · Christian Mottet, Holm H Uhlig, et al. · The Journal of Immunology · 929
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
2009 · Gert Van Assche, Axel Dignass, et al. · Journal of Crohn s and Colitis · 891
PDF
Control of intestinal inflammation by regulatory T cells
2001 · Baljit Singh, Simon Read, et al. · Immunological Reviews · 500
Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activityin vitro
2001 · Leigh A. Stephens, Christian Mottet, et al. · European Journal of Immunology · 486
PDF
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
2006 · Holm H Uhlig, Janine Coombes, et al. · The Journal of Immunology · 464
Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease
2016 · Antonina Mikocka-Walus, Valerie Pittet, et al. · Clinical Gastroenterology and Hepatology · 348
PDF
In vitro–expanded donor alloantigen–specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance
2006 · Dela Golshayan, Shuiping Jiang, et al. · Blood · 313
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
2011 · Stephan R. Vavricka, Sabrina M. Spigaglia, et al. · Inflammatory Bowel Diseases · 245
Control of Immune Pathology by Regulatory T Cells
2003 · Fiona Powrie, Simon Read, et al. · Novartis Foundation symposium · 136
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study
2018 · Levente Parragi, N Fournier, et al. · Journal of Crohn s and Colitis · 123
PDF
Extraintestinal Manifestations of Crohn’s Disease
2005 · Pascal Juillerat, Christian Mottet, et al. · Digestion · 91
Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy
2007 · Christoph Beglinger, Jean Dudler, et al. · Swiss Medical Weekly · 84
TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update
2020 · Marianne Vulliemoz, Stephan Brand, et al. · Digestion · 75
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel
2013 · Valerie Pittet, Florian Froehlich, et al. · Journal of Crohn s and Colitis · 66
Topical therapy is underused in patients with ulcerative colitis
2013 · F. Seibold, N. Fournier, et al. · Journal of Crohn s and Colitis · 64
PDF
The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years
2019 · Nadia Pillai, Mark Dusheiko, et al. · Journal of Crohn s and Colitis · 59
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort
2018 · Matiar Madanchi, Stefania Fagagnini, et al. · Inflammatory Bowel Diseases · 59
PDF
Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response
2000 · Alena Donda, Lucia Mori, et al. · European Journal of Immunology · 58
PDF
CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use
2007 · C Mottet, D Golshayan · Swiss Medical Weekly · 54
Extraintestinal Manifestations of Crohn’s Disease
2007 · Pascal Juillerat, Christian Mottet, et al. · Digestion · 53
The gap between scientific evidence and clinical practice: 5‐aminosalicylates are frequently used for the treatment of Crohn's disease
2014 · A. M. Schoepfer, M. Bortolotti, et al. · Alimentary Pharmacology & Therapeutics · 50
Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: Biological roles and effects of TNF and TNF antagonists
2010 · Yehuda Chowers, Andreas Sturm, et al. · Journal of Crohn s and Colitis · 47
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study
2007 · Pascal Juillerat, Valérie Pittet, et al. · Journal of Crohn s and Colitis · 47
PDF
Fistulizing Crohn’s Disease
2005 · Christian Felley, Christian Mottet, et al. · Digestion · 45
Penetrating or Stricturing Diseases are the Major Determinants of Time to First and Repeat Resection Surgery in Crohn's Disease
2013 · Valerie Pittet, Gerhard Rogler, et al. · Digestion · 44
PDF
Works count: 181
Citation count: 6,593
H-index: 34
I10-index: 70
Year
Topic
Type